11:49 AM EST - Neovasc Inc. : Announced the U.S. Food and Drug Administration has granted approval for participating physicians to treat patients with its 40mm Tiara™ valve in the Company's TIARA-I Early Feasibility Trial. Neovasc Inc.
shares T.NVC are trading up $0.19 at $6.29.
